PCIDB

KNApSAcK Metabolite C00001248

Metabolite

KNApSAcK Entry

id C00001248
Name Dodecane
CAS RN 112-40-3
Standard InChI InChI=1S/C12H26/c1-3-5-7-9-11-12-10-8-6-4-2/h3-12H2,1-2H3
Standard InChI (Main Layer) InChI=1S/C12H26/c1-3-5-7-9-11-12-10-8-6-4-2/h3-12H2,1-2H3

Cluster

Phytochemical cluster
KCF-S cluster No. 877

Link

ChEMBL

By standard InChI CHEMBL30959
By standard InChI Main Layer CHEMBL30959

KEGG

By LinkDB C08374

CTD

By CAS RN C007548

Human Protein / Gene in interaction

1 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
Q9UBT6 DNA polymerase kappa Enzyme CHEMBL30959 CHEMBL1794536 (1)
0 / 0

CTD interaction (3)

compound gene gene name gene description interaction interaction type form reference
pmid
C007548 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha n-dodecane results in increased expression of and results in increased secretion of IL1A protein increases expression
/ increases secretion
protein 19720135
C007548 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) n-dodecane results in increased expression of and results in increased secretion of IL6 protein increases expression
/ increases secretion
protein 19720135
C007548 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 n-dodecane results in increased expression of and results in increased secretion of IL8 protein increases expression
/ increases secretion
protein 19720135

Related Disease

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D017453 C007548 Dermatitis, Irritant marker/mechanism
19152832
D004890 C007548 Erythema marker/mechanism
19720135